• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  cyclosporine
Trade Name:  Verkazia
Date Designated:  05/04/2007
Orphan Designation:  Treatment of vernal keratoconjunctivitis
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  06/23/2021 
Approved Labeled Indication:  Treatment of vernal keratoconjunctivitis (VKC) in children and adults
Exclusivity End Date:    06/23/2028 
Exclusivity Protected Indication* :  Treatment of vernal keratoconjunctivitis (VKC) in children and adults
Santen SAS
Batiment Genavenir IV
F-91058-Evry cedex
France

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-